237 related articles for article (PubMed ID: 8332195)
1. Direct interaction of Ras and the amino-terminal region of Raf-1 in vitro.
Warne PH; Viciana PR; Downward J
Nature; 1993 Jul; 364(6435):352-5. PubMed ID: 8332195
[TBL] [Abstract][Full Text] [Related]
2. Single cell Ras-GTP analysis reveals altered Ras activity in a subpopulation of neurofibroma Schwann cells but not fibroblasts.
Sherman LS; Atit R; Rosenbaum T; Cox AD; Ratner N
J Biol Chem; 2000 Sep; 275(39):30740-5. PubMed ID: 10900196
[TBL] [Abstract][Full Text] [Related]
3. High-Affinity Interaction of the K-Ras4B Hypervariable Region with the Ras Active Site.
Chavan TS; Jang H; Khavrutskii L; Abraham SJ; Banerjee A; Freed BC; Johannessen L; Tarasov SG; Gaponenko V; Nussinov R; Tarasova NI
Biophys J; 2015 Dec; 109(12):2602-2613. PubMed ID: 26682817
[TBL] [Abstract][Full Text] [Related]
4. Homogeneous Dual-Parametric-Coupled Assay for Simultaneous Nucleotide Exchange and KRAS/RAF-RBD Interaction Monitoring.
Kopra K; Vuorinen E; Abreu-Blanco M; Wang Q; Eskonen V; Gillette W; Pulliainen AT; Holderfield M; Härmä H
Anal Chem; 2020 Apr; 92(7):4971-4979. PubMed ID: 32106676
[TBL] [Abstract][Full Text] [Related]
5. GTP-Dependent K-Ras Dimerization.
Muratcioglu S; Chavan TS; Freed BC; Jang H; Khavrutskii L; Freed RN; Dyba MA; Stefanisko K; Tarasov SG; Gursoy A; Keskin O; Tarasova NI; Gaponenko V; Nussinov R
Structure; 2015 Jul; 23(7):1325-35. PubMed ID: 26051715
[TBL] [Abstract][Full Text] [Related]
6. Allosteric effects of the oncogenic RasQ61L mutant on Raf-RBD.
Fetics SK; Guterres H; Kearney BM; Buhrman G; Ma B; Nussinov R; Mattos C
Structure; 2015 Mar; 23(3):505-516. PubMed ID: 25684575
[TBL] [Abstract][Full Text] [Related]
7. Bifunctional Small-Molecule Ligands of K-Ras Induce Its Association with Immunophilin Proteins.
Zhang Z; Shokat KM
Angew Chem Int Ed Engl; 2019 Nov; 58(45):16314-16319. PubMed ID: 31557383
[TBL] [Abstract][Full Text] [Related]
8. Predicted 'wiring landscape' of Ras-effector interactions in 29 human tissues.
Catozzi S; Halasz M; Kiel C
NPJ Syst Biol Appl; 2021 Feb; 7(1):10. PubMed ID: 33580066
[TBL] [Abstract][Full Text] [Related]
9. Mutations in the α4-α5 allosteric lobe of RAS do not significantly impair RAS signaling or self-association.
Whaby M; Wallon L; Mazzei M; Khan I; Teng KW; Koide S; O'Bryan JP
J Biol Chem; 2022 Dec; 298(12):102661. PubMed ID: 36334633
[TBL] [Abstract][Full Text] [Related]
10. Conserved allosteric perturbation of the GTPase domains by region 1 of Ras hypervariable regions.
Gu X; Zhang Y; Long D
Biophys J; 2024 Apr; 123(7):839-846. PubMed ID: 38419331
[TBL] [Abstract][Full Text] [Related]
11. Profiling Complex RAS-Effector Interactions Using NMR Spectroscopy.
Strakhova R; Smith MJ
Methods Mol Biol; 2024; 2797():195-209. PubMed ID: 38570461
[TBL] [Abstract][Full Text] [Related]
12. Myotubularin-related-protein-7 inhibits mutant (G12V) K-RAS by direct interaction.
Weidner P; Saar D; Söhn M; Schroeder T; Yu Y; Zöllner FG; Ponelies N; Zhou X; Zwicky A; Rohrbacher FN; Pattabiraman VR; Tanriver M; Bauer A; Ahmed H; Ametamey SM; Riffel P; Seger R; Bode JW; Wade RC; Ebert MPA; Kragelund BB; Burgermeister E
Cancer Lett; 2024 Apr; 588():216783. PubMed ID: 38462034
[TBL] [Abstract][Full Text] [Related]
13. Investigation of GTP-dependent dimerization of G12X K-Ras variants using ultraviolet photodissociation mass spectrometry.
Mehaffey MR; Schardon CL; Novelli ET; Cammarata MB; Webb LJ; Fast W; Brodbelt JS
Chem Sci; 2019 Sep; 10(34):8025-8034. PubMed ID: 31853358
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory effect of flavonoids on mutant H-Rasp protein.
Masoodi TA; Alhamdanz AH
Bioinformation; 2010 Jun; 5(1):11-5. PubMed ID: 21346872
[TBL] [Abstract][Full Text] [Related]
15. Complexes of Ras.GTP with Raf-1 and mitogen-activated protein kinase kinase.
Moodie SA; Willumsen BM; Weber MJ; Wolfman A
Science; 1993 Jun; 260(5114):1658-61. PubMed ID: 8503013
[TBL] [Abstract][Full Text] [Related]
16. Mammalian Ras interacts directly with the serine/threonine kinase Raf.
Vojtek AB; Hollenberg SM; Cooper JA
Cell; 1993 Jul; 74(1):205-14. PubMed ID: 8334704
[TBL] [Abstract][Full Text] [Related]
17. Driver Mutations in Pancreatic Cancer and Opportunities for Targeted Therapy.
Olaoba OT; Adelusi TI; Yang M; Maidens T; Kimchi ET; Staveley-O'Carroll KF; Li G
Cancers (Basel); 2024 May; 16(10):. PubMed ID: 38791887
[TBL] [Abstract][Full Text] [Related]
18. KRAS4b:RAF-1 Homogenous Time-Resolved Fluorescence Resonance Energy Transfer Assay for Drug Discovery.
Larsen EK; Abreu-Blanco M; Rabara D; Stephen AG
Methods Mol Biol; 2024; 2797():159-175. PubMed ID: 38570459
[TBL] [Abstract][Full Text] [Related]
19. Mutations in the Serine/Threonine Kinase BRAF: Oncogenic Drivers in Solid Tumors.
Roa P; Bremer NV; Foglizzo V; Cocco E
Cancers (Basel); 2024 Mar; 16(6):. PubMed ID: 38539548
[TBL] [Abstract][Full Text] [Related]
20. The role of CRAF in cancer progression: from molecular mechanisms to precision therapies.
Riaud M; Maxwell J; Soria-Bretones I; Dankner M; Li M; Rose AAN
Nat Rev Cancer; 2024 Feb; 24(2):105-122. PubMed ID: 38195917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
